Pfizer Recalls More Than 100,000 Bottles of Effexor XR
Pfizer Inc. (NYSE:PFE) is recalling two lots of its antidepressant drug Effexor XR, as well as one lot of the generic version of the drug, after a pharmacist reported that one bottle of Pfizer’s Effexor XR contained one capsule of another drug, Pfizer’s Tikosyn, mixed in with the Effexor capsules.
“Although Pfizer has not received any other such reports, these three lots are being voluntarily recalled as a precaution because they were packaged on the same line,” a Pfizer press release, issued Thursday states.
The three lots of the drug, which is known as venlafaxine in its generic form, total about 104,450 bottles; about 65,800 of those bottles had made it to pharmacies in the U.S. when the recall was issued. The recall composes two 30-count lots of Effexor XR and one 90-count lot of the generic version, which is made by Greenstone LLC, a company owned by Pfizer.
Effexor XR is a prescription antidepressant medication that is used in patients with major depressive disorder, general anxiety disorder, social anxiety disorder, and panic disorder.